AbbVie 2013 Annual Report Download - page 145

Download and view the complete annual report

Please find page 145 of the 2013 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 176

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176

Discussion of Performance Goals and Results for Each Named Executive Officer
2013 Financial Goals
Name Goal and Expected Result Results Achieved
Richard A. Gonzalez . . A. Adjusted Diluted EPS of A. Achieved—$3.14
$3.03 - $3.13
B. AbbVie Sales of $18,529MM B. Achieved—$18,790MM
C. Adjusted Income Before Taxes C. Achieved—$6,515MM
of $6,300MM
D. Adjusted Return on Assets of D. Achieved—24.3%
17%
E. Adjusted Return on Equity of E. Achieved—115.2%
40%
Laura J. Schumacher . . A. Adjusted Diluted EPS of A. Achieved—$3.14
$3.03 - $3.13
B. AbbVie Sales of $18,529MM B. Achieved—$18,790MM
William J. Chase ...... A. Adjusted Diluted EPS of A. Achieved—$3.14
$3.03 - $3.13
B. AbbVie Sales of $18,529MM B. Achieved—$18,790MM
Carlos Alban ........ A. Adjusted Diluted EPS of A. Achieved—$3.14
$3.03 - $3.13
B. AbbVie Sales of $18,529MM B. Achieved—$18,790MM
C. Achieve AbbVie Humira Sales C. Achieved—$10,659MM
of $10,288MM
Timothy J. Richmond . . A. Adjusted Diluted EPS of A. Achieved—$3.14
$3.03 - $3.13
B. AbbVie Sales of $18,529MM B. Achieved—$18,790MM
Other 2013 Goals
Richard A. Gonzalez
Goals: Build investor confidence in the company and management; Drive exceptional business
performance despite the loss of exclusivity of the lipid franchise; Successfully advance mid- and late-
stage pipeline; Build the AbbVie brand identity with key stakeholders; Effect a successful transition
from Abbott; Develop a strategic roadmap to drive top tier, sustainable long-term performance;
Establish a strong, competent and engaged leadership team; Start the transformation of AbbVie’s
culture to a biopharmaceutical model; Transform/build a world class research and development
organization; Drive strong employee engagement and motivation around the AbbVie mission and
future prospects.
Results: Mr. Gonzalez achieved the above goals in all material aspects.
Laura J. Schumacher
Goals: Successfully continue to develop and implement strategies to effectively resolve key
litigation matters; Achieve proprietary pharmaceutical pipeline enhancement objectives; Execute
biologics strategic development initiatives; Support research and development initiatives per company
strategy.
22